Log in to save to my catalogue

Using chanarin-dorfman syndrome patient fibroblasts to explore disease mechanisms and new treatment...

Using chanarin-dorfman syndrome patient fibroblasts to explore disease mechanisms and new treatment...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a52b73a0b18d430b82bfcd2ed6549887

Using chanarin-dorfman syndrome patient fibroblasts to explore disease mechanisms and new treatment avenues

About this item

Full title

Using chanarin-dorfman syndrome patient fibroblasts to explore disease mechanisms and new treatment avenues

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2025-04, Vol.20 (1), p.195-13, Article 195

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chanarin-Dorfman syndrome (CDS) is a multisystemic autosomal recessive rare disorder. CDS is caused by variants in the abhydrolase domain containing 5 (ABHD5) encoding gene (CGI-58), which ultimately leads to excessive lipid storage, and therefore a high abundance of cellular lipid droplets (LDs). Although the molecular etiology of the disease was...

Alternative Titles

Full title

Using chanarin-dorfman syndrome patient fibroblasts to explore disease mechanisms and new treatment avenues

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a52b73a0b18d430b82bfcd2ed6549887

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a52b73a0b18d430b82bfcd2ed6549887

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-025-03711-6

How to access this item